1 Alder H,Taccioli C,Chen H,et al. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer[J]. Carcinogenesis,2012,33(9):1736-1744. 2 Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2):69-90. 3 Sempere LF,Christensen M,Silahtaroglu A,et al. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer[J]. Cancer Res,2007,67(24):11612-11620. 4 Markou A,Yousef G M,Stathopoulos E,et al. Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up[J]. Clin Chem,2014,60(1):197-205. 5 Mitchell PS,Parkin RK,Kroh EM,et al. Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Nat Acad,2008,105(30):10513-10518. 6 Dong H,Lei J,Ding L,et al. MicroRNA:function,detection,and bioanalysis.[J]. Chem Rev,2013,113(8):6207-6233. 7 Godfrey AC,Xu Z,Weinberg CR,et al. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort[J]. Breast Cancer Res,2013,15(3):1-10. 8 Zhang H,Li B,Zhao H,et al. The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers[J]. Int J Clin Exp Med,2015,8(2):3034-3043. 9 Ma L,Teruyafeldstein J,Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J]. Nature,2007,449(7163):682-688. 10 Ma L,Reinhardt F,Pan E,et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model[J]. Nat Biotechnol,2010,28(4):341-347. 11 Chou J,Lin JH,Brenot A,et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression[J]. Nat Cell Biol,2013,15(2):201-213. 12 Scott GK,Goga A,Bhaumik D,et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b[J]. J Biol Chem,2007,282(2):1479-1486. 13 Zhang HD,Sun DW,Mao L,et al. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel[J]. Biochem Biophys Rese Commun,2015,465(4):702-713. 14 Wu J,Li S,Jia W,et al. Reduced Let-7a is associated with chemoresistance in primary breast cancer[J]. PloS One,2015,10(7):e0133643. 15 Zhou M,Liu Z,Zhao Y,et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1)[J]. J Biol Chem,2010。285(28):21496-21507. 16 Xie X,Hu Y,Xu L,et al. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer[J]. Tumour Biol,2015,36(9):7185-7194. 17 Vilquin P,Donini C F,Villedieu M,et al. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer[J]. Int J Cancer,2015,17(1):1-20. 18 Jung EJ,Santarpia L,Kim J,et al. Plasma miR-210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients[J]. Cancer,2012,118(10):2603–2614. 19 Gong C,Yao Y,Wang Y,et al. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer[J]. J Biol Chem,2011,286(21):19127-19137. 20 Radojicic J,Zaravinos A,Vrekoussis T,et al. MicroRNA expression analysis in triple-negative (ER,PR and Her2/neu) breast cancer[J]. Cell Cycle,2011,10(3):507-517. 21 Ugoff K,Mccue B,Plow EF,et al. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer[J]. Mol Cancer,2011,11(1):5. 22 Savad S,Mehdipour P,Miryounesi M,et al. Expression analysis of MiR-21,MiR-205,and MiR-342 in breast cancer in Iran[J]. Asian Pac J Cancer Prev,2012,13(3):873-877. 23 Nassirpour R,Mehta PP,Baxi SM,et al. miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells[J]. PloS One,2013,8(4):542-542. 24 Chen W,Zheng X,Shen C,et al. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells[J]. J Exp Clin Cancer Res,2012,31(18):1-8. 25 Kong W,He L,Richards EJ,et al. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer[J]. Oncogene,2013,33(6):679–689.